CRISCuris, Inc.

$15M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+14.1% YoY

Gross Profit

$2M99.4% margin

Operating Income

-$10M-426.8% margin

Net Income

-$11M-446.1% margin

EPS (Diluted)

$-1.25

QoQ Revenue Growth

-28.8%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$39M

Total Liabilities

$46M

Stockholders' Equity

-$7M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+14.1%
Gross Profit	$2M	$2M	+16.0%
Operating Income	-$10M	-$12M	+18.5%
Net Income	-$11M	-$12M	+10.6%

Revenue Segments

Reportable Segment

$2M100%

CRIS Q1 2025 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena